Jamjoom Pharma provides SAR 17.7M corporate guarantee to Algeria JV

21/01/2024 Argaam
Logo ofJamjoom Pharmaceutical Factory Co.

Logo of Jamjoom Pharmaceutical Factory Co.

Jamjoom Pharmaceutical Factory Co.’s board of directors approved on Jan. 18 providing a corporate guarantee to Natixis Algérie to support the issuance of a Shariah-compliant short-term revolving banking facility at a total of DZD 1.3 billion (SAR 36.2 million).

 

The purpose of the banking facility is to fund short-term working capital requirements, the company said in a statement to Tadawul.

 

The corporate guarantee is in accordance with the Algerian law and is in proportion to the company’s shareholding in the joint venture, therefore, Jamjoom Pharma will be guaranteeing DZD 637 million (SAR 17.7 million).

 

Meanwhile, the company noted that its board members, Mahmoud Yousuf Jamjoom, Mohammed Yousuf Jamjoom and Ahmed Yousuf Jamjoom are related parties given that they each holds a board seat at Jamjoom Algeria Lil Dawa SPA.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.